Moolec Science (MLEC) Change in Working Capital (2023 - 2024)
Moolec Science (MLEC) reported Change in Working Capital of -$2.7 million for Q4 2024, down 73.97% on a YoY basis from -$10.2 million in Q1 2024, and down 73.97% sequentially from -$1.5 million in Q4 2023.
Moolec Science (MLEC) Change in Working Capital (2023 - 2024) Analysis & Trends
Moolec Science (MLEC) has 2 years of Change in Working Capital data on file, last reported at -$2.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.66 Mn |
| Dec 31, 2024 | -2.66 Mn |
| Dec 31, 2023 | -1.53 Mn |
| Dec 31, 2023 | -1.53 Mn |